Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sobrero

Showing results (11-20 of 69) with videos related to

Pageof 7
Sort By:
Cancer Research|April 1, 1992
Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedulesC Aschele, A Sobrero, M A Faderan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracilC Aschele, D Debernardis, G Tunesi, et al.
Anticancer Research|March 1, 1989
Very high dose cis-platinum (450 mg/sq m) in an infant with rhabdomyosarcomaR Haupt, G Perin, S Dallorso, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1990
Resistance to 5-fluorouracil and 5-fluoro-2'-deoxyuridine mechanisms and clinical implicationsA Sobrero, C Aschele, A Guglielmi, et al.
Journal of the National Cancer Institute|January 2, 1991
Rapid development of resistance to antifolates in vitro: possible clinical implicationA Sobrero, C Aschele, R Rosso, et al.
Tumori|June 30, 1984
Leucovorin protection on pluripotent hemopoietic stem cells in mice treated with high-dose methotrexateC Muzzulini, F D'Amore, A Sobrero, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Design and rationale for novel antifolatesJ R Bertino, A Sobrero, E Mini, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1989
Sequence-dependent enhancement of HCT-8 cell kill by trimetrexate and fluoropyrimidines: implications for the mechanism of this interactionA Sobrero, A Romanini, O Russello, et al.
Cancer Research|August 15, 1993
Decreased folylpolyglutamate synthetase expression: a novel mechanism of fluorouracil resistanceF S Wang, C Aschele, A Sobrero, et al.
Cancer Treatment Reports|December 1, 1982
Activity of 4'-epi-doxorubicin on normal hematopoietic precursor cells in miceA Sobrero, C Muzzulini, F D'Amore, et al.
Pageof 7

Showing results (11-20 of 69) with videos related to

Sort By:
Pageof 7
Cancer Research|April 1, 1992
Novel mechanism(s) of resistance to 5-fluorouracil in human colon cancer (HCT-8) sublines following exposure to two different clinically relevant dose schedulesC Aschele, A Sobrero, M A Faderan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2001
Thymidylate synthase protein expression in primary colorectal cancer compared with the corresponding distant metastases and relationship with the clinical response to 5-fluorouracilC Aschele, D Debernardis, G Tunesi, et al.
Anticancer Research|March 1, 1989
Very high dose cis-platinum (450 mg/sq m) in an infant with rhabdomyosarcomaR Haupt, G Perin, S Dallorso, et al.
Journal of Chemotherapy (Florence, Italy)|February 1, 1990
Resistance to 5-fluorouracil and 5-fluoro-2'-deoxyuridine mechanisms and clinical implicationsA Sobrero, C Aschele, A Guglielmi, et al.
Journal of the National Cancer Institute|January 2, 1991
Rapid development of resistance to antifolates in vitro: possible clinical implicationA Sobrero, C Aschele, R Rosso, et al.
Tumori|June 30, 1984
Leucovorin protection on pluripotent hemopoietic stem cells in mice treated with high-dose methotrexateC Muzzulini, F D'Amore, A Sobrero, et al.
NCI Monographs : a Publication of the National Cancer Institute|January 1, 1987
Design and rationale for novel antifolatesJ R Bertino, A Sobrero, E Mini, et al.
European Journal of Cancer & Clinical Oncology|June 1, 1989
Sequence-dependent enhancement of HCT-8 cell kill by trimetrexate and fluoropyrimidines: implications for the mechanism of this interactionA Sobrero, A Romanini, O Russello, et al.
Cancer Research|August 15, 1993
Decreased folylpolyglutamate synthetase expression: a novel mechanism of fluorouracil resistanceF S Wang, C Aschele, A Sobrero, et al.
Cancer Treatment Reports|December 1, 1982
Activity of 4'-epi-doxorubicin on normal hematopoietic precursor cells in miceA Sobrero, C Muzzulini, F D'Amore, et al.
Pageof 7